These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6343858

  • 1. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.
    Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA.
    Muscle Nerve; 1983 Feb; 6(2):91-103. PubMed ID: 6343858
    [Abstract] [Full Text] [Related]

  • 2. Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine.
    Moxley RT, Brooke MH, Fenichel GM, Mendell JR, Griggs RC, Miller JP, Province MA, Patterson V.
    Muscle Nerve; 1987 Jan; 10(1):22-33. PubMed ID: 3550455
    [Abstract] [Full Text] [Related]

  • 3. Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.
    Mendell JR, Griggs RC, Moxley RT, Fenichel GM, Brooke MH, Miller JP, Province MA, Dodson WE.
    Muscle Nerve; 1984 Sep; 7(7):535-41. PubMed ID: 6399927
    [Abstract] [Full Text] [Related]

  • 4. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
    Desnuelle C, Serratrice G, N'guyen VK, Richelme C, Pinsard N.
    Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lack of benefit of allopurinol in Duchenne dystrophy.
    Mendell JR, Wiechers DO.
    Muscle Nerve; 1979 Dec; 2(1):53-6. PubMed ID: 397411
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
    Toifl K, Presterl E, Graninger W.
    Wien Klin Wochenschr; 1991 Dec; 103(8):232-5. PubMed ID: 1907056
    [Abstract] [Full Text] [Related]

  • 11. [Effect of sinestrol on the course of the myodystrophic process in progressive Duchenne muscular dystrophy].
    Zavadenko NN, Kamennykh LN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989 Dec; 89(8):41-5. PubMed ID: 2686320
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M, Fábregues I, Campistol J, Fernández Alvarez E, Alvarez M.
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
    Buchanan DC, Roelofs RI, White DK, Saavedra de Arango G.
    Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.
    Zatz M, Betti RT, Frota-Pessoa O.
    Am J Med Genet; 1986 Jul; 24(3):549-66. PubMed ID: 3524231
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Duchenne muscular dystrophy. Therapeutic principles and status after 14 years].
    Hinge HH, Hein-Sørensen O.
    Ugeskr Laeger; 1990 Mar 26; 152(13):897-900. PubMed ID: 2321304
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.